4.7 Review

Recent Updates in Experimental Research and Clinical Evaluation on Drugs for COVID-19 Treatment

Journal

FRONTIERS IN PHARMACOLOGY
Volume 12, Issue -, Pages -

Publisher

FRONTIERS MEDIA SA
DOI: 10.3389/fphar.2021.732403

Keywords

corona virus disease 2019; corona virus disease 2019 treatment; severe acute respiratory syndrome corona virus 2 variants; antimicrobials; immunotherapy; traditional Chinese medicine

Ask authors/readers for more resources

The COVID-19 outbreak since December 2019 has posed a huge threat to global public health. Various clinical studies are evaluating the efficacy of different treatments against COVID-19 to control and prevent the spread of the outbreak.
Since the outbreak of corona virus disease 2019 (COVID-19) in Wuhan (China) in December 2019, the epidemic has rapidly spread to many countries around the world, posing a huge threat to global public health. In response to the pandemic, a number of clinical studies have been initiated to evaluate the effect of various treatments against COVID-19, combining medical strategies and clinical trial data from around the globe. Herein, we summarize the clinical evaluation about the drugs mentioned in this review for COVID-19 treatment. This review discusses the recent data regarding the efficacy of various treatments in COVID-19 patients, to control and prevent the outbreak.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available